Sign in
4

Changes in Ownership

Niagen Bioscience, Inc. Filed Acc 0001415889-20-002560

CHIEF FINANCIAL OFFICER bought 5,000 shares at $4.43 ($22,150)

From the SEC's structured data for this filing

Trades in this filing

FARR KEVIN M · CHIEF FINANCIAL OFFICER

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2020-11-06 Purchase : show line 1 in the form +5,000 $4.43 $22,150 41,625 D
Open-market purchases · 5,000 sh · avg $4.43 · $22,150
Loading xslF345X03/form4-11062020_011109.xml…